-
The huge container ship that struck the Key Bridge had electrical problems the day before it left the Port of Baltimore, according to a preliminary report released Tuesday by federal investigators.
-
Caitlin Clark has sold out arenas nationwide. But can she, alongside 2023's Rookie of the Year Aliyah Boston, turn around the league's worst team? Or will the Las Vegas Aces pull off a three-peat?
-
Secretary of State Antony Blinken made an unannounced visit to Kyiv and said some new U.S. aid already arrived and more will reach the battlefield in the coming weeks.
-
The detonation marked a major step in freeing the Dali, which has been stuck among the wreckage since it crashed into one of the bridge's support columns shortly after leaving Baltimore on March 26.
-
The Carol Shields Prize for Fiction is a relatively new literary award given to women and nonbinary authors. This year's winner is V.V. Ganeshananthan for her book Brotherless Night.
-
At the European Hospital in Rafah, there are shortages of pain medication, antibiotics, even bandages, American volunteers say they are unable to save lives — and unable to evacuate to safety.
-
French Gates says she is "immensely proud" of the work of the Bill and Melinda Gates Foundation, and the decision to step down as co-chair was not easy. Her last day is June 7.
-
Girl Scouts Troop 6,000 in New York City helps migrant girls establish connections and a platform to start a new life in a new country but also equips them with crucial life skills.
-
The adult contemporary star, who became a reluctant giant of smooth jazz in the 1980s, died on Sunday after a six-year battle with prostate cancer.
-
The bill faces a likely veto from Georgia's president, which parliament can override. Protesters who oppose the measure say it is modeled on a Russian law used to clamp down on dissent.
-
Shares in the video game retailer more than doubled at one point after a prominent meme stock investor made his first online posting in about three years.
-
Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them.